The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer

Recently, an anti-angiogenic strategy to treat gastric cancer (GC) has been successful with the use of ramucirumab. The comprehensive network of VEGF, soluble VEGF receptor-2 (sVEGFR2) and cytokines and other angiogenic factors (CAF) in GC has not been reported. We aimed to reveal the CAF signature...

Full description

Saved in:
Bibliographic Details
Published in:Am J Cancer Res
Main Authors: Ock, Chan-Young, Nam, Ah-Rong, Bang, Ju-Hee, Kim, Tae-Yong, Lee, Kyung-Hun, Han, Sae-Won, Im, Seock-Ah, Kim, Tae-You, Bang, Yung-Jue, Oh, Do-Youn
Format: Artigo
Language:Inglês
Published: e-Century Publishing Corporation 2015
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4697684/
https://ncbi.nlm.nih.gov/pubmed/26807318
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items